Literature DB >> 22904304

Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.

Claudio Procaccini1, Veronica De Rosa, Mario Galgani, Fortunata Carbone, Silvana Cassano, Dario Greco, Kui Qian, Petri Auvinen, Gaetano Calì, Giovanni Stallone, Luigi Formisano, Antonio La Cava, Giuseppe Matarese.   

Abstract

The sensing by T cells of metabolic and energetic changes in the microenvironment can determine the differentiation, maturation, and activation of these cells. Although it is known that mammalian target of rapamycin (mTOR) gauges nutritonal and energetic signals in the extracellular milieu, it is not known how mTOR and metabolism influence CD4+CD25-FOXP3- effector T cell (Teff) responses. In this article, we show that leptin-induced activation of mTOR, which, in turn, controls leptin production and signaling, causes a defined cellular, biochemical, and transcriptional signature that determine the outcome of Teff responses, both in vitro and in vivo. The blockade of leptin/leptin receptor signaling, induced by genetic means or by starvation, leads to impaired mTOR activity that inhibits the proliferation of Teffs in vivo. Notably, the transcriptional signature of Teffs in the presence of leptin blockade appears similar to that observed in rapamycin-treated Teffs. These results identify a novel link between nutritional status and Teff responses through the leptin-mTOR axis and define a potential target for Teff modulation in normal and pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22904304     DOI: 10.4049/jimmunol.1200935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes.

Authors:  Sothea Touch; Karine Clément; Sébastien André
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

2.  Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.

Authors:  L Cantarini; V Pucino; A Vitale; R Talarico; O M Lucherini; F Magnotti; V De Rosa; M Galgani; C Alviggi; G Marone; M Galeazzi; G Matarese
Journal:  Clin Exp Immunol       Date:  2016-02-24       Impact factor: 4.330

3.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

Review 4.  The bioenergetics of inflammation: insights into obesity and type 2 diabetes.

Authors:  K N Keane; E K Calton; R Carlessi; P H Hart; P Newsholme
Journal:  Eur J Clin Nutr       Date:  2017-04-12       Impact factor: 4.016

Review 5.  Hypothalamic roles of mTOR complex I: integration of nutrient and hormone signals to regulate energy homeostasis.

Authors:  Fang Hu; Yong Xu; Feng Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

Review 6.  mTOR and metabolic regulation of conventional and regulatory T cells.

Authors:  Chaohong Liu; Nicole M Chapman; Peer W F Karmaus; Hu Zeng; Hongbo Chi
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

Review 7.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

Review 8.  Immunometabolism, pregnancy, and nutrition.

Authors:  Kristin Thiele; Lianghui Diao; Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2017-10-25       Impact factor: 9.623

9.  Oscillatory mTOR inhibition and Treg increase in kidney transplantation.

Authors:  M Sabbatini; G Ruggiero; A T Palatucci; V Rubino; S Federico; A Giovazzino; L Apicella; M Santopaolo; G Matarese; M Galgani; G Terrazzano
Journal:  Clin Exp Immunol       Date:  2015-08-28       Impact factor: 4.330

Review 10.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.